The present invention relates to a method of enhancing cognition without producing convulsions which method comprises administering to a subject in need thereof a cognition enhancing amount of a compound which is a GABAa selective alpha5 receptor inverse agonist.
Preparation and use of a specific GABA-Aalpha5 receptor ligand for treatment of Alzheimer's disease